Обзор компании

Альбом компании31

Основная информация
UNIQUE company has over 25 years experience for health care product, we have the factory over 40000 square meters and 10000 square meters GMP workshop to produce the products. Our products have the certificate for CE, ISO and approved by FDA. UNIQUE can supply zinc oxide adhesive plaster, Band-Aid, sterile dressing stick, infusion paste, medical tape, elastic bandages, medical tape,and other products. Totally over one hundred products, lots of them supply to the major hospitals, the majority of doctors and patients praise for it, Band-Aid, tapes and dressings posted the most influential products in domestic which market share has been ranked the top threeFor international market, we have the customers in United States, Germany, Japan, Russia, Italy, Brazil, Argentina and other dozens of well-known international companies and trade institutions to establish a long-term and stable partnership, foreign direct ordering and export customized products, increasing year by year, product worldwide enjoy high visibility and brand influence. Unique company adhere to scientific and technological innovation, in order to accelerate the optimization and upgrading of products, we increased investment for research and development funds, also cooperate with Zhejiang University and Third Military Medical University for new product.
3.2/5
Приемлемый
3 Reviews
  • 22 Транзакции
    20,000+
  • Время отклика
    ≤9h
  • Частота откликов
    86.36%
Тип компании
Производитель, Торговая компания
Страна / Регион
Guangdong, China
Основные продуктыВсего сотрудников
11 - 50 People
Общий годовой доход
US$1 Million - US$2.5 Million
Год основания
2014
Сертификаты
-
Сертификаты на продукцию
-
Патенты
-
Товарные знаки
-
Основные рынки

Емкость продукта

Информация о заводе

Размер завода
30,000-50,000 square meters
Местоположение завода
China
Число производственных линий
7
Контрактное производство
OEM Service Offered, Design Service Offered, Buyer Label Offered
Годовой выпуск
US$50 Million - US$100 Million

R&D возможности

Исследования и разработки

41 - 50 People